Before injecting, check the liquid to ensure its clear and colorless
Everyones body and health journey is different, so its important to look at the full picture
"Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP1R)"
GLP-1 agonists promote the release of insulin in response to hyperglycaemia, inhibit the secretion of glucagon, slow gastric emptying, and augment satiety by directly affecting the central nervous system 1
Your team monitors your progress every four weeks and adjusts your plan as needed
However, patients may experience minor side effects, such as injection site reactions (redness, swelling, or itching) or gastrointestinal symptoms (nausea, vomiting, or diarrhea)